JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Classification of Legg-Calvé-Perthes disease.

Although the etiology of Perthes disease remains unknown 100 years after its first description, there are many articles that describe the disease course, final outcome, and results of treatment. A system of classification of the extent and severity of the disease is essential to understanding variability of Perthes, and along with the age of the patient when first affected, is useful in predicting long-term outcomes. Published reports of treatment strategies and their success depend on effective classification of the disease severity and radiographic result at final follow-up concerning head sphericity, congruency with the acetabulum, and arthritis. This article reviews published articles that contain classification systems and details presently used systems that are helpful in understanding and in treating Perthes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app